Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 186,672 | 190,170 | 187,797 | 181,330 | 168,035 |
| Cost of Goods | 105,808 | 106,827 | 107,351 | 104,072 | 94,789 |
| Gross Profit | 80,864 | 83,343 | 80,446 | 77,258 | 73,246 |
| Operating Expenses | 99,913 | 97,584 | 107,811 | 124,958 | 101,860 |
| Operating Income | -18,241 | -13,414 | -27,014 | -47,628 | -27,825 |
| Interest Expense | 598 | 599 | 603 | 933 | 1,618 |
| Other Income | 1,261 | 1,607 | 1,228 | 2,745 | 3,786 |
| Pre-tax Income | -17,578 | -12,406 | -26,389 | -45,816 | -25,657 |
| Income Tax | -472 | -2,525 | 740 | -724 | 266 |
| Net Income Continuous | -17,106 | -9,881 | -27,129 | -45,092 | -25,923 |
| Net Income | $-17,106 | $-9,881 | $-27,129 | $-45,092 | $-25,923 |
| EPS Basic Total Ops | -0.13 | -0.08 | -0.21 | -0.35 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.08 | -0.21 | -0.35 | -0.20 |
| EPS Diluted Total Ops | -0.13 | -0.08 | -0.21 | -0.35 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.08 | -0.21 | -0.35 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.06 | 0.00 | -0.05 | -0.06 | -0.08 |
| EBITDA(a) | $-1,828 | $3,364 | $-10,196 | $-29,131 | $-10,097 |